Monitoring antigen-specific T cells using MHC-Ig dimers.
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 29 (2) , 163-169
- https://doi.org/10.3109/08820130009062300
Abstract
To summarize, two novel approaches are currently being examined that allow for identification of antigen-specific T cells. A biochemical approach to generating soluble multivalent MHC complexes has been to generate tetrameric MHC complexes linked to avidin. We have also generated a general approach for producing soluble divalent versions of class I and class II MHC molecules, using Ig as a molecular scaffold. The experimental system described here outlines a general approach of using multivalent high affinity ligands to study cell-cell interactions, driven by multivalent ligand-receptor interactions. Our work indicates that divalent chimeric molecules are high-avidity analogs of proteins useful in probing and selectively regulating cellular responses.Keywords
This publication has 7 references indexed in Scilit:
- Soluble, High-Affinity Dimers of T-Cell Receptors and Class II Major Histocompatibility Complexes: Biochemical Probes for Analysis and Modulation of Immune ResponsesCellular Immunology, 1999
- Potent T Cell Activation with Dimeric Peptide–Major Histocompatibility Complex Class II Ligand: The Role of CD4 CoreceptorThe Journal of Experimental Medicine, 1998
- Initiation of Signal Transduction through the T Cell Receptor Requires the Multivalent Engagement of Peptide/MHC LigandsImmunity, 1998
- Direct visualization of antigen-specific T cells: HTLV-1 Tax11–19- specific CD8+T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patientsProceedings of the National Academy of Sciences, 1998
- Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral InfectionImmunity, 1998
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.Proceedings of the National Academy of Sciences, 1993